LN的流行病学特征复杂多样，受种族、地域、社会经济等多种因素影响；其发病机制涉及遗传、环境（包括紫外线、空气污染、病毒感染、肠道菌群与食物因素）、免疫等多个方面，是多种因素相互作用的结果。深入研究这些方面，有助于开发更精准的诊断方法和更有效的治疗策略 ...

March is here, and as we observe Kidney Month, it’s crucial to raise awareness about how lupus can severely impact the ...

1 The purpose of ALMS was to demonstrate the superiority of mycophenolate mofetil (MMF) over intravenous cyclophosphamide for the induction of remission in patients with lupus nephritis.

In a new study, researchers investigated microRNA-203 as a potential biomarker for lupus nephritis (LN) and found that ...

1 More than 1.5 million people develop one of the most dangerous manifestations of SLE: lupus nephritis (LN), characterized by immune system induced inflammation of the kidneys. Within 10 years ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody plus standard ...

Adding obinutuzumab to standard therapy for active lupus nephritis led to significantly higher rates of complete renal ...

Nat Clin Pract Nephrol. 2007;3(6):296-297. How did this transfer of 'ownership' of lupus nephritis to rheumatologists happen? There are two possible reasons. Either rheumatologists hijacked lupus ...

The following is a summary of “Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis,” published in the February 2025 ...